Welcome to the ValueWiki Pharmaxis Limited (PXSL) article! Register for free or click the "edit" link to contribute!    

Pharmaxis Limited (PXSL)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about Pharmaxis Limited? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max





Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

11/21/08 3:11 pm Foot Locker, SL Green Rlty and Pharmaxis lead small-cap percentage losers (SmallCapInvestor.com)
11/05/08 4:11 pm Orient Express Hotels, Bridge Capital Holdings and Obagi Medical Products among 52-week lows (SmallCapInvestor.com)
10/19/08 6:10 pm Pharmaxis Aridol Approved for Sale in Switzerland (PR Newswire)
10/13/08 2:10 am Pharmaxis Investor Conference Call (PR Newswire)
10/02/08 7:10 pm Pharmaxis Research Programs Highlighted at European Respiratory Society Congress (PR Newswire)
09/30/08 7:09 pm ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia (PR Newswire)
09/19/08 8:09 am PHARMAXIS LTD. Financials (EDGAR Online Financials)
09/04/08 1:09 am Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins (PR Newswire)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

Pharmaxis Limited Snapshot
Pharmaxis Limited Leadership
Pharmaxis Limited Fundamentals
Pharmaxis Limited Technical Analysis
Pharmaxis Limited Message Boards

Notes

  1. This is a sample reference.
Personal tools